Do you want to read an article? Please log in or register.
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
Epilepsy
Related content
Epilepsy
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
Epilepsia.
Devinsky O, Nabbout R, Miller I, Laux L, Zolnowska M, Wright S, Roberts C
doi: 10.1111/epi.
Epilepsy
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V
doi: 10.1111/epi.16484.
Epilepsy
Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
Epilepsia.
Krauss GL, Perucca E, Kwan P, Ben-Menachem E, Wang XF, Shih JJ, Patten A, Yang H, Williams B, Laurenza A
doi: 10.1111/epi.14044.
Epilepsy
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia.
Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT
doi: 10.1111/epi.16573.
EpilepsyMigraine and Headache
Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial
Epilepsia.
Vossler DG, Wechsler RT, Williams P, Byrnes W, Therriault S;
ALEX-MT study group
doi: 10.1111/epi.13502.
RECOMMENDED
Migraine and Headache
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Cephalalgia.
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R, Raskin J, Pearlman EM, Kudrow D
doi: 10.1177/0333102419864132.
Migraine and Headache
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
J Headache Pain.
Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A
doi: 10.1186/s10194-018-0840-8.
Migraine and Headache
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
BMC Neurol.
Camporeale A, Kudrow D, Sides R, Wang S, Van Dycke A, Selzler KJ, Stauffer VL
doi: 10.1186/s12883-018-1193-2.
Epilepsy
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
N Engl J Med.
Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, Zuberi SM; GWPCARE Study Group
doi: 10.1056/NEJMoa1714631.